50% of DOAC Doses are Inappropriate in Older Adults? On The Role of Appropriate Dosing
Anticoagulation Forum shared on LinkedIn:
”Did you know? Up to 50% of DOAC doses are inappropriate in older adults—with underdosing being more common than overdosing.
Underdosing can actually increase the risk of stroke, systemic embolism, and cardiovascular hospitalizations, without reducing bleed risk.
This new resource, Clinical Considerations: Anticoagulation Use in Older Adults, provides practical guidance on:
- Dosing best practices
- Managing fall risk
- Addressing modifiable bleeding risk factors
- Choosing the right anticoagulant through individualized, shared decision-making
Read the full resource here.
Then, test your knowledge with our Show You Know Quiz and see how your clinical decision-making stacks up.
This resource was made possible through our collaboration with the American Pharmacists Association (APhA), with support from an educational grant by the Bristol Myers Squibb and Pfizer Alliance.
Special thanks to our expert content developers and reviewers: Christina Bookwalter PharmD, MS MEd, BCPS, BCACP, Stacey Kaplon, PharmD, BCACP, Katie Meyer, PharmD, BCPS, BCGP, Amanda McFee Winans, PharmD, BCPS, CACP.”

Stay informed on the latets in the field of anticoagulation with Hemostasis Today.
-
Dec 12, 2025, 23:51Don’t Miss: IACH Post ASH 2025 Roundtable Debate
-
Dec 12, 2025, 23:37C-Reactive Protein and Cardiovascular Risk in the General Population: A European Heart Journal Study by Berkan Kurt et al.
-
Dec 12, 2025, 23:23Alta Schutte and Colleagues at National Hypertension Taskforce: Driving Single-Pill Therapy for Hypertension and More
-
Dec 12, 2025, 22:27Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:27Abdul Mannan: When Blood Clots Show Up in Unexpected Places
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
